lenvatinib

AKT serine/threonine kinase 1 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35236826 Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis. 2022 Mar 2 2
2 35238496 Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. 2022 Mar 3 4
3 35252056 MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met. 2022 1
4 35489726 Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib. 2022 May 4
5 33148422 Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. 2021 Jan 1 2
6 33419805 Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer. 2021 Jan 3
7 33609067 Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. 2021 Apr 1
8 33670725 Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models. 2021 Feb 18 1
9 33995632 Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT. 2021 3
10 31853327 Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways. 2020 Jan 1
11 29517103 Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. 2018 May 1